Skip to main content

Health condition

Mounjaro patient guide

Mounjaro (tirzepatide) is a weekly injection licensed in the UK for type 2 diabetes and for weight management - the most effective weight-loss medication licensed to date.

Key points

What matters most, at a glance.

The essentials in plain English - symptoms, when to seek help, who to see and what treatment looks like.

  • Acts on two gut hormones (GIP and GLP-1) to reduce appetite and improve glucose control

  • Trials showed average weight loss of around 15-20% at the highest doses

  • Available on the NHS in phased rollout through specialist and GP-led services for people meeting BMI criteria

  • Also available privately through regulated pharmacies and weight-management clinics with a clinical assessment

  • Common side effects: nausea, constipation and diarrhoea, usually easing as doses settle

Understanding it

About Mounjaro patient guide, and what to do next.

Tirzepatide combines two hormone actions in one weekly injection, curbing appetite, slowing stomach emptying and improving insulin response. In the SURMOUNT trials, people without diabetes lost on average around a fifth of their body weight at the top dose alongside diet and activity support - results approaching those of some bariatric surgery.

In the UK it is licensed for weight management at BMI 30+ (or 27+ with weight-related conditions) and NHS access is being phased in, prioritising those with the highest need; private prescriptions require a proper clinical assessment by a regulated provider. It is a long-term treatment, and weight commonly returns if it is stopped without a maintenance plan. Most people start with their GP, who can refer to a weight-management clinic. NHS routine referrals often take 20-45+ weeks depending on where you live, while a private consultation is typically available within about two weeks.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them.

Frequently asked

Common questions about Mounjaro patient guide.

Quick, plain-English answers to what people ask us most.

  • What is Mounjaro and what is it used for?

    Mounjaro is the brand name for tirzepatide, an injectable medication licensed for type 2 diabetes and, at certain doses, for weight management. It works by mimicking two gut hormones that regulate blood sugar and appetite.

  • How does Mounjaro work?

    Mounjaro activates GIP and GLP-1 receptors, hormones involved in insulin release, appetite regulation and slowing stomach emptying, which together help lower blood sugar and reduce hunger and food intake.

  • What are the common side effects of Mounjaro?

    The most common side effects are gastrointestinal, including nausea, diarrhoea, constipation and reduced appetite, which tend to be more noticeable when starting or increasing the dose and often settle over time.

  • Is Mounjaro safe to use?

    Mounjaro has been through clinical trials and is licensed for use, but like all medications it carries risks and isn't suitable for everyone, including people with certain thyroid cancer history or severe gastrointestinal disease, so medical assessment before starting is important.

  • How much weight can be lost with Mounjaro?

    Clinical trials have shown substantial average weight loss with tirzepatide at higher doses when combined with lifestyle changes, though individual results vary considerably, and it's intended to be used alongside diet and exercise, not as a standalone solution.

  • How is Mounjaro administered and monitored?

    Mounjaro is given as a weekly injection, usually starting at a low dose that's gradually increased to reduce side effects, with regular monitoring of weight, blood sugar and any side effects by a prescribing clinician.

  • What happens if I stop taking Mounjaro?

    Appetite and blood sugar control typically return towards baseline after stopping, and weight regain is common without continued lifestyle changes, which is why many clinicians recommend viewing it as part of a longer-term management plan rather than a short course.

  • When should I see a doctor about starting Mounjaro, and how quickly can I be seen privately?

    See a doctor to discuss suitability, dosing and monitoring before starting Mounjaro, particularly if you have other health conditions. Private weight management or diabetes clinics can often arrange an assessment and prescription within about two weeks.